Not exact matches
In response to Sessions» comments, entrepreneurs in the legal
industry and marijuana advocates oppose the Senator's nomination to attorney general, where he would have power
over U.S.
drug policy.
According to
Industry Canada, Big Pharma spends more than $ 1.3 billion a year on R&D — and many global
drug makers are increasingly looking at Canada for top talent and a cost - competitive advantage
over the United States.
Last year the
drug industry spent
over $ 100 million on those ubiquitous adverts featuring Moose et al..
And the defiant stance actually may have boosted the
drug maker's image at a time when Americans are skeptical about the pharmaceutical
industry over high
drug prices.
«The manufacturer of a
drug has no influence or control
over the prices charged by a secondary wholesaler to a hospital or pharmacy,» reads part of a statement on the PhRMA web site, the
industry's trade association group.
JERUSALEM — Israeli generic
drug maker Teva Pharmaceutical
Industries on Thursday said first - quarter earnings surged
over 80 percent and raised its outlook for the rest of the year, citing progress in an aggressive restructuring plan.
The PBM
industry, which manages
over $ 370B in prescription
drug - spending, provides limited and fragmented services, forcing plan sponsors to outsource critical functions to multiple vendors.
JERUSALEM (AP)-- Israeli generic
drug maker Teva Pharmaceutical
Industries on Thursday said first - quarter earnings surged
over 80 percent and raised...
The latter is particularly important as regulatory approval for new
drugs hinges on accurate data, and public trust in the pharma
industry has ebbed and flowed
over the years as stories of fabricated results make headlines.
Investments in fast - growing
industries like the technology and healthcare sectors (which have historically been volatile) could result in increased price fluctuation, especially
over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new
drugs and medical instruments.
Investments in fast - growing
industries like the technology and health care sectors (which have historically been volatile) could result in increased price fluctuation, especially
over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new
drugs and medical instruments.
He has been in the
drug industry for
over 30 years.
Recent reports of secret meetings among
industry reps and the Food and
Drug Adminstration
over GMO labeling piqued my interest, mostly because this critical aspect was missing: any effort to label GE foods at the federal level could bring the current grassroots movement to a grinding halt by preventing any stronger local laws from ever being enacted.
To give you a sense of where the arena is headed, we'll also describe
over the course of the month new
industry initiatives that are intended to improve the
drug discovery process.
In 2006, the neurotechnology
industry comprised
over 500 companies, developing
drugs, devices and diagnostics for the brain and nervous system, generating worldwide revenues of $ 120.5 billion.
Although pharma -
industry positions have long been considered stable, the global recession and fundamental concerns about the way
drugs are developed have resulted in massive
industry layoffs
over the past 2 years.
Facing bipartisan hostility
over high
drug prices in an election year, the pharma
industry's biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups, new filings show.
In the past two decades, the pharmaceutical
industry has spent
over $ 2.5 billion to develop new schizophrenia
drugs.
Over the course of several years, the CRI Cancer Immunotherapy Consortium (CIC), a group of 100 academic and
industry partners in the cancer immunotherapy space, has worked with a broad and diverse network of immunologists,
drug developers, and regulatory agency representatives to establish a new paradigm for clinical development and evaluation of cancer immunotherapies.
«They fell out of favor not because they didn't work, but because the
drug industry took
over medicine, so things like coffee enemas were kind of laughed at,» Dr. Gonzalez says.
Winnipeg, MB, Canada About Blog Canada
Drugs as the leading online drugstore has earned many Canadian pharmacy accreditations and
over our ten years of operation we have become
industry leaders in product knowledge, prescription choice, quality and safety.
In April, MtGox had
over 70 % market share in the Bitcoin exchange
industry, BitPay was by far the largest payment processor, and the Bitcoin
drug market, which many thought was crucial to the Bitcoin economy, was dominated by Silk Road.
Dawn Standerwick is a seasoned
industry professional with
over 26 years of experience in all facets of workforce screening and has extensive knowledge in background screening,
drug testing, occupational health testing, and related HR technologies.
Employment Screening, Inc. (ESI) has
over 20 years experience in the background screening and
drug testing
industry.
Aurico is a background screening and
drug testing company located in the northwest suburbs of Chicago with
over 3000 clients spanning all
industry sectors.
Dedicated, self - motivated research scientist with
over 15 years
drug discovery experience seeking a challenging opportunity in biotech - pharmaceutical
industry where I can enhance and utilize my technical expertise to contribute to new
drug development and server the patients.
DIRECTOR OF R&D I have
over 15 years of success in Director of R&D roles and a track record of commercializing technologies for medical device, therapeutic,
drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process,
industry collaborations, licenses, and start - ups.